{"slideshow_credits": null, "snippet": "The pharmaceutical trade group writes that F.D.A. policies should include sharing more information about the evolving use of medicines.", "abstract": null, "section_name": "Opinion", "print_page": "34", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2015/11/11/opinion/adult-drugs-for-children.html", "lead_paragraph": "The pharmaceutical trade group writes that F.D.A. policies should include sharing more information about the evolving use of medicines.", "headline": {"print_headline": "Adult Drugs for Children", "main": "Adult Drugs for Children", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "5642fa7538f0d842ce0a8981", "word_count": "222", "multimedia": [], "pub_date": "2015-11-11T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Children and Childhood", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}